Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
about
Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherenceAre all biases missing data problems?Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessmentsMapping Soil Transmitted Helminths and Schistosomiasis under Uncertainty: A Systematic Review and Critical Appraisal of EvidenceInfluenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for biasData for cancer comparative effectiveness research: past, present, and future potential.Misclassification in administrative claims data: quantifying the impact on treatment effect estimates.Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' replyThiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates.Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.Propensity score-based sensitivity analysis method for uncontrolled confoundingRelative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Evaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues.Propensity score calibration in the absence of surrogacyAsthma Associates With Human Abdominal Aortic Aneurysm and Rupture.Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Efficient sampling approaches to address confounding in database studies.Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified samplingValidation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness.Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinicianA review of covariate selection for non-experimental comparative effectiveness research.Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.Confounding control in healthcare database research: challenges and potential approaches.Methodological considerations of the GRADE method.Use of statin during hospitalization improves the outcome after intracerebral hemorrhage.Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
P2860
Q24658518-3DB5A176-FEF2-4B93-8FCF-D142C95A7819Q28393758-46A47D40-C535-4209-9FB9-B2DD13466931Q28396918-45672D33-D663-44A5-B479-1927460998ABQ28397065-68F37F15-D22E-4D7A-AFC4-E093E3C0E465Q28742116-DF2E1DC1-733A-441E-A71F-6E8AB0BD66A0Q30416509-98875BE8-B2C6-46FC-B417-808ED46C9166Q30974376-731B0319-BECB-495E-B387-91DC158981E2Q31109187-BF67451D-127F-42AF-AF37-230A6ED0B12DQ33561519-9C490AA3-B334-4929-8994-6B1D5046FDADQ34217441-0309D2EF-AC8D-452B-9904-72F6E3F7CA4FQ34254280-7E543048-AB68-4422-AF91-40684E406BE1Q34441060-190BACD2-C639-41C3-9383-E67A773ABF7CQ35450663-D383B5A9-C455-4289-B6BC-2B1B6913379FQ35774970-559F366A-4D76-446E-BBA7-2E468414CF88Q36363886-888B32DF-9444-43ED-A5B2-DCE45B955C99Q36380007-73C4B869-FF05-43BB-9D0D-EB29821DC419Q36619430-29C4A099-A539-4AD0-AE51-16E49A9EFD1BQ36742039-C70358A9-C7BE-4F45-A807-D12E1C494250Q37278227-C4164F4B-C744-4954-B5D2-9B808CBBA888Q37278735-38208381-4795-4985-A891-2F0FE8113380Q37397345-8E32B49D-ED23-4FE5-96D6-D65281D8A014Q37548259-4B66E118-A2E1-4C58-96F7-A2079DC632B3Q37735783-E3CD1167-D9D5-42E8-92CC-CB3253C1E558Q38134365-43454A88-D1EA-4C5F-A2F8-7D69A05A89E1Q38811363-C95F3B37-C2FC-401B-ACAD-EBDB96756D6EQ38976502-4E95A024-997A-4A7E-B115-D220731CB0A1Q39700269-8DB143A7-7FE0-4256-BAF5-CE56E1A23A7DQ43191873-24318FF1-0D20-461F-8A7C-F4C39EF5ACF6Q45350350-25AFBB1F-F55A-4B8A-AC5C-26684FE1F9D6Q48767268-5C00AA1F-2E4B-40B3-A555-EDDC11EE45F7
P2860
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Adjustments for unmeasured con ...... es using external information.
@ast
Adjustments for unmeasured con ...... es using external information.
@en
type
label
Adjustments for unmeasured con ...... es using external information.
@ast
Adjustments for unmeasured con ...... es using external information.
@en
prefLabel
Adjustments for unmeasured con ...... es using external information.
@ast
Adjustments for unmeasured con ...... es using external information.
@en
P2093
P2860
P1433
P1476
Adjustments for unmeasured con ...... es using external information.
@en
P2093
Jerry Avorn
Robert J Glynn
Sebastian Schneeweiss
P2860
P304
P356
10.1097/MLR.0B013E318070C045
P433
P577
2007-10-01T00:00:00Z